Latest News in the pharma Industry

Market News

Exscientia enters strategic drug discovery collaboration with GSK

Exscientia enters strategic drug discovery collaboration with GSK

2 Jul 2017

Pre-clinical collaboration focused on up to 10 targets nominated by GSK.

Read more 
Patheon to invest $45 million, expanding capabilities to support continued growth

Patheon to invest $45 million, expanding capabilities to support continued growth

2 Jul 2017

Investments in commercial and development spray drying, and flexible manufacturing solutions.

Read more 
Bioverativ completes acquisition of True North Therapeutics

Bioverativ completes acquisition of True North Therapeutics

29 Jun 2017

Strengthens leadership in rare blood disorders with first-in-class candidate to treat cold agglutinin disease, a chronic autoimmune hemolytic anemia with no approved therapies.

Read more 
First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel

First prostate cancer patients treated with Augmenix's SpaceOAR Hydrogel in Israel

29 Jun 2017

The Chaim Sheba Medical Center now offers the hydrogel spacer to reduce side-effects during prostate cancer radiation therapy.

Read more 
Copley Scientific releases upgraded SPU 2000 for reduced inhaler testing variability

Copley Scientific releases upgraded SPU 2000 for reduced inhaler testing variability

29 Jun 2017

Company's modification makes the SPU 2000 a more cost effective laboratory tool.

Read more 
BASF plans significant investment in ibuprofen capacities in Germany and North America

BASF plans significant investment in ibuprofen capacities in Germany and North America

28 Jun 2017

New world-scale ibuprofen production plant in Ludwigshafen; additional capacity expansion of ibuprofen plant in Bishop, Texas.

Read more 
UK availability of Rixathon and Erelzi paves way for NHS savings

UK availability of Rixathon and Erelzi paves way for NHS savings

28 Jun 2017

Two new biosimilar medicines available to treat patients with specific blood cancers and a range of inflammatory condition.

Read more 
Vectura enters new development and licence agreement for a US inhaled generic

Vectura enters new development and licence agreement for a US inhaled generic

28 Jun 2017

Agreement concerns an existing inhaled combination therapy for asthma and COPD delivered using a pMDI.

Read more 
LifeArc, Dstl and CDRD collaborate to identify antibacterial drug targets

LifeArc, Dstl and CDRD collaborate to identify antibacterial drug targets

27 Jun 2017

Novel approach capitalises on commonality across pathogens.

Read more 
Allergan introduces REFRESH OPTIVE MEGA-3 enhanced with flaxseed oil

Allergan introduces REFRESH OPTIVE MEGA-3 enhanced with flaxseed oil

27 Jun 2017

New offering restores lipid layer and brings hydration to all three layers of tear film damaged by Dry Eye.

Read more 
Bioconjugation specialist Innova Biosciences acquired by SYGNIS

Bioconjugation specialist Innova Biosciences acquired by SYGNIS

27 Jun 2017

Innova’s range of antibody and protein labeling products and services ideally complements SYGNIS’ customer base and existing genomics and proteomics portfolio.

Read more 
QS Pharma receives approval from EMA for commercial manufacture

QS Pharma receives approval from EMA for commercial manufacture

27 Jun 2017

The CDMO is now approved to manufacture medicinal products for the US, Europe and Japan.

Read more